Junji Furuse

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Topics

Liver Metastases

Clinical Practice

Histone Deacetylase

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

International journal of clinical oncology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Junji Furuse, Fumihiko Osugi, Koji Machii, Koji Niibe, Toshimitsu Endo
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan. International journal of clinical oncology 29 (4) (2024)
Junji Furuse, Fumihiko Osugi, Koji Machii, Koji Niibe, Toshimitsu Endo
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan. International journal of clinical oncology 29 (4) (2024)
Junji Furuse, Masafumi Ikeda, Makoto Ueno, Masayuki Furukawa, Chigusa Morizane, Tetsuo Takehara, Tomohiro Nishina, Akiko Todaka, Naohiro Okano, Kazuo Hara, Yousuke Nakai, Kazuyoshi Ohkawa, Takashi Sasaki, Kazuya Sugimori, Naoyuki Yokoyama, Kouji Yamamoto
Phase II Placebo-Controlled Study of the Effect and Safety of Nanvuranlat in Patients with Advanced Biliary Tract Cancers Previously Treated by Systemic Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, Do Youn Oh, John A Bridgewater, Masashi Shimura, Bailey Anderson, Nanae Hangai, Volker Wacheck, Lipika Goyal
Safety Profile and Adverse Event Management for Futibatinib, an Irreversible FGFR1-4 Inhibitor: Pooled Safety analysis of 469 patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Junji Furuse, Fumihiko Osugi, Koji Machii, Koji Niibe, Toshimitsu Endo
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan. International journal of clinical oncology 29 (4) (2024)
Junji Furuse, Fumihiko Osugi, Koji Machii, Koji Niibe, Toshimitsu Endo
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan. International journal of clinical oncology 29 (4) (2024)
Junji Furuse, Fumihiko Osugi, Koji Machii, Koji Niibe, Toshimitsu Endo
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan. International journal of clinical oncology (2024)
Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, Do Youn Oh, John A Bridgewater, Masashi Shimura, Bailey Anderson, Nanae Hangai, Volker Wacheck, Lipika Goyal
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, Do Youn Oh, John A Bridgewater, Masashi Shimura, Bailey Anderson, Nanae Hangai, Volker Wacheck, Lipika Goyal
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, Do Youn Oh, John A Bridgewater, Masashi Shimura, Bailey Anderson, Nanae Hangai, Volker Wacheck, Lipika Goyal
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Akihiro Ohba, Chigusa Morizane, Yasuyuki Kawamoto, Yoshito Komatsu, Makoto Ueno, Satoshi Kobayashi, Masafumi Ikeda, Mitsuhito Sasaki, Junji Furuse, Naohiro Okano, Nobuyoshi Hiraoka, Hiroshi Yoshida, Aya Kuchiba, Ryo Sadachi, Kenichi Nakamura, Naoko Matsui, Yoshiaki Nakamura, Wataru Okamoto, Takayuki Yoshino, Takuji Okusaka
Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2-Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Junji Furuse, Namiki Izumi, Kenta Motomura, Yoshitaka Inaba, Yoshio Katamura, Yasuteru Kondo, Kazuhisa Yabushita, Katsuaki Motoyoshi, Masatoshi Kudo
Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan. Drugs - real world outcomes (2023)
Satoshi Kobayashi, Motoko Suzuki, Makoto Ueno, Yuta Maruki, Naohiro Okano, Akiko Todaka, Masato Ozaka, Kunihiro Tsuji, Kazuhiko Shioji, Keitaro Doi, Yasushi Kojima, Hidetaka Tsumura, Kazunari Tanaka, Hajime Higuchi, Ken Kawabe, Hiroshi Imaoka, Tatsuya Yamashita, Haruo Miwa, Hiroaki Nagano, Shiho Arima, Hideyuki Hayashi, Atsushi Naganuma, Hironori Yamaguchi, Terumasa Hisano, Kumiko Umemoto, Shuji Ishii, Koji Nakashima, Rei Suzuki, Yohei Kitano, Toshihiro Misumi, Junji Furuse, Hiroshi Ishii
Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer. The oncologist 27 (10) (2022)
Makoto Ueno, Chigusa Morizane, Masayuki Furukawa, Daisuke Sakai, Yoshito Komatsu, Yousuke Nakai, Masahiro Tsuda, Masato Ozaka, Nobumasa Mizuno, Manabu Muto, Akira Fukutomi, Masafumi Ikeda, Akihito Tsuji, Akio Katanuma, Toshikazu Moriwaki, Takeshi Kajiwara, Hiroshi Ishii, Yuji Negoro, Satoshi Shimizu, Noriko Nemoto, Shingo Kobayashi, Keigo Makino, Junji Furuse
A randomized, double-blind, phase II study of oral histone deacetylase inhibitor resminostat plus S-1 versus placebo plus S-1 in biliary tract cancers previously treated with gemcitabine plus platinum-based chemotherapy. Cancer medicine 10 (6) (2021)
Masatoshi Kudo, Manabu Morimoto, Michihisa Moriguchi, Namiki Izumi, Tetsuji Takayama, Hitoshi Yoshiji, Keisuke Hino, Takayoshi Oikawa, Tetsuhiro Chiba, Kenta Motomura, Junko Kato, Kentaro Yasuchika, Akio Ido, Takashi Sato, Daisuke Nakashima, Kazuomi Ueshima, Masafumi Ikeda, Takuji Okusaka, Kazuo Tamura, Junji Furuse
A randomized, double-blind, placebo-controlled, phase 3 study of tivantinib in Japanese patients with MET-high hepatocellular carcinoma. Cancer science 111 (10) (2020)
Makoto Ueno, Shoji Nakamori, Kazuya Sugimori, Masashi Kanai, Masafumi Ikeda, Masato Ozaka, Masayuki Furukawa, Takuji Okusaka, Ken Kawabe, Junji Furuse, Yoshito Komatsu, Hiroshi Ishii, Atsushi Sato, Satoshi Shimizu, Priti Chugh, Rui Tang, Tatsuya Ioka
nal-IRI+5-FU/LV versus 5-FU/LV in post-gemcitabine metastatic pancreatic cancer: Randomized phase 2 trial in Japanese patients. Cancer medicine 9 (24) (2020)
Masakazu Yamamoto, Masahiro Yoshida, Junji Furuse, Keiji Sano, Masayuki Ohtsuka, Shingo Yamashita, Toru Beppu, Yukio Iwashita, Keita Wada, Takako Eguchi Nakajima, Katsunori Sakamoto, Koichi Hayano, Yasuhisa Mori, Koji Asai, Ryusei Matsuyama, Teijiro Hirashita, Taizo Hibi, Nozomu Sakai, Tsutomu Tabata, Hiasto Kawakami, Hiroyuki Takeda, Takuro Mizukami, Masato Ozaka, Makoto Ueno, Yoichi Naito, Naohiro Okano, Takayuki Ueno, Susumu Hijioka, Satoru Shikata, Tomohiko Ukai, Steven Strasberg, Michael G Sarr, Palepu Jagannath, Tsann-Long Hwang, Ho-Seong Han, Yoo-Seok Yoon, Hee Jung Wang, Shao-Ciao Luo, René Adam, Mariano Gimenez, Olivier Scatton, Do-Youn Oh, Tadahiro Takada
Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021. Journal of hepato-biliary-pancreatic sciences 28 (1) (2020)
Takafumi Koyama, Toshio Shimizu, Satoru Iwasa, Yutaka Fujiwara, Shunsuke Kondo, Shigehisa Kitano, Kan Yonemori, Akihiko Shimomura, Sakura Iizumi, Tatsuya Sasaki, Junji Furuse, Noboru Yamamoto
First-in-human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors. Cancer science 111 (2) (2020)
Junji Furuse
Paradigm Shifting of Systemic Chemotherapy for Unresectable Pancreatic Cancer in Japan. Journal of clinical medicine 8 (8) (2019)
Masafumi Ikeda, Tatsuya Ioka, Akira Fukutomi, Chigusa Morizane, Akiyoshi Kasuga, Hideaki Takahashi, Akiko Todaka, Takuji Okusaka, Caretha L Creasy, Shelby Gorman, Daniel J Felitsky, Mikiro Kobayashi, Fanghong Zhang, Junji Furuse
Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine. Cancer science 109 (1) (2017)